- In normal physiology
- AVDO2 remains relatively constant
- CBF changes in accordance to CMRO2 / CMRG.
- Ischaemic injury consists of
- Infarct core
- Undergoes hypoxia- induced loss of cellular homeostasis and necrosis, .
- Penumbra
- Apoptotic processes can be targeted for therapeutic intervention
- Cerebral ischaemia occurs when CBF does not meet cerebral metabolic demands (e.g. low CBF and high AVDO2).
- Ways to measure
- Jugular bulb oximetry
- Transcranial doppler
- PET
- Demonstrated that previous definitions of hyperaemia and ischaemia based on CBF and oxygen are inaccurate,
- Maintaining oxygen delivery may not be sufficient to prevent secondary injury.
- Due to Mitochondrial dysfunction see above
- Head injury → mitochondrial dysfunction → decreases oxygen demand + transition to hyperglycolysis → lactate accumulation.
- Here a dec. In CBF can be misinterpreted as ischaemia
- Ischaemia is often seen in
- Acute SDH
- Diffuse cerebral swelling
- Inadequate metabolic supply to the brain after TBI is predictive of high morbidity and disability.
- In head injury
- Autoregulation is lost in TBI
- The ability of CBF to meet metabolic demands is impaired,
- AVDO2 may increase to improve O2 extraction in the cerebral circulation.
- AVDO2 is capable of increasing from baseline value 6.7 ml/ 100 ml to a maximum 13 ml/ 100 ml.
- The normal CBF threshold at which AVDO2 compensation occurs is 18 ml/ 100 g/ min, and can rise to 20 ml/ 100 g/ min following TBI due to decreased oxidative metabolism.
- 15 O PET shows that diffusion barrier ischaemia (increased oxygen diffusion gradient from vasculature to interstitium) is due to microvascular disturbances such a perivascular oedema surrounding traumatic lesions → decreased partial pressure of oxygen in brain tissue (PbO2).
- Neuronal death
- Mech
- Caspases and other proteins directly causing neuronal death,
- 3 distinct mitogen- activated protein kinase (MAPK) inflammatory pathways contribute to ischaemic injury:
- Extracellular signal- regulated kinase (ERK) pathway,
- c- Jun- N- terminal protein kinase (JNK) pathway,
- p38 pathway.
- Biomarkers used in the assessment of neuronal, glial, and axonal damage.
- Neuron- specific enolase
- Is a glycolytic enzyme predominantly in neurons.
- S100B
- A calcium binding protein predominantly in astroglia.
- Myelin basic protein
- Located in white matter
- A marker for axonal damage.